Zeneca Pharma S.A.
Records under this name other than patents Zeneca Pharma S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US RE42,353 | Quinazoline Derivatives and Pharmaceutical Compositions Containing Them Formerly held Term ended Term ended Jun 27, 2022 · Low confidence | Term ended | Term ended Jun 27, 2022 | Low confidence |
| US 6,258,951 | Chemical compounds Formerly held Term ended Term ended Feb 9, 2020 · From the USPTO record | Term ended | Term ended Feb 9, 2020 | From the USPTO record |
| US 6,071,921 | Chemical compounds Formerly held Term ended Term ended Dec 2, 2018 · From the USPTO record | Term ended | Term ended Dec 2, 2018 | From the USPTO record |
| US 6,673,803 | Quinazoline Derivatives and Pharmaceutical Compositions Containing Them Formerly held Term ended Term ended Sep 23, 2017 · Medium confidence | Term ended | Term ended Sep 23, 2017 | Medium confidence |
| US 6,897,210 | Quinazoline Derivatives and Pharmaceutical Compositions Containing Them Formerly held Term ended Term ended Sep 23, 2017 · Medium confidence | Term ended | Term ended Sep 23, 2017 | Medium confidence |
| US 6,362,336 | Chemical compounds Formerly held Term ended Term ended Dec 17, 2016 · Medium confidence | Term ended | Term ended Dec 17, 2016 | Medium confidence |
| US 6,291,455 | 4-anilinoquinazoline derivatives Formerly held Lapsed on the fee record Ended Sep 18, 2013 · From the USPTO record | Lapsed on the fee record | Ended Sep 18, 2013 | From the USPTO record |
| US 6,809,097 | Quinoline derivatives inhibiting the effect of growth factors such as VEGF Formerly held Lapsed on the fee record Ended Oct 26, 2012 · From the USPTO record | Lapsed on the fee record | Ended Oct 26, 2012 | From the USPTO record |
| US 6,414,148 | Quinazoline derivatives and pharmaceutical compositions containing them Formerly held Surrendered on reissue Surrendered on reissue May 10, 2011 · From the USPTO record | Surrendered on reissue | Surrendered on reissue May 10, 2011 | From the USPTO record |
| US 6,514,971 | Cinnoline derivatives and use as medicine Formerly held Lapsed on the fee record Ended Feb 4, 2011 · From the USPTO record | Lapsed on the fee record | Ended Feb 4, 2011 | From the USPTO record |